Company: HURA
Filing Date: 2025-05-06
Form Type: S-4/A
Source: 0001193125-25-113920
Chunk: 1029

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-06
Form: S-4/A
Chunk 1029
---
                         |     |                                                                | ☒                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |     |       |     |       |       |
|                                                                                                                                                                                                                                                  |     | Signature of Officer or Authorized Signer                      |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |     |       |     | Title |       |
|                                                                                                                                                                                                                                                  |     |                                                                | ☒                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |     |       |     |       |       |
|                                                                                                                                                                                                                                                  |     |                                                                | Signature of Officer or Authorized Signer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |     |       |     |       | Title |
|                                                                                                                                                                                                                                                  |     |                                                                | *  If any proposed amendment would alter or change any preference or any relative or other right given to any class or series of outstanding shares, then the amendment must be approved by the vote, in addition to the affirmative vote otherwise required, of the holders of shares representing a majority of the voting power of each class or series affected by the amendment regardless to limitations or restrictions on the voting power thereof.                                                                                             |     |       |     |       |       |
| Please include any required or optional information in space below: (attach additional page(s) if necessary)                                                                                                                                     |     |                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |     |       |     |       |       |
| Article SECOND of the Articles of Incorporation of TuHURA Biosciences, Inc. has been amended in its entirety to read as follows:   NUMBER OF SHARES WITH PAR VALUE: 200,000,000 COMMON - $0.001 PAR VALUE 5,000,000 PREFERRED - $0.001 PAR VALUE |     |                                                                |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |     |       |     |       |       |

| This form must be accompanied by appropriate fees. |     | Page 2 of 2       |
|                                                    |     | Revised: 9/1/2023 |

C-2

<div align='center'>**ANNEX D: PLAN OF CONVERSION

OF

TUHURA BIOSCIENCES, INC.**</div>

THIS PLAN OF CONVERSION (this “Plan”), dated as of [●], 2025, is entered into by TuHURA Biosciences, Inc., a Nevada corporation (“TuHURA Nevada”), for the purpose of converting TuHURA Nevada into a Delaware corporation proposed to be known as TuHURA Biosciences, Inc. (the “Converted Entity”), in accordance with Section 92A.105 of the Nevada Revised Statutes (“